Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Cardiology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006.Circulation. 2009; 119: 1085-1092
- Does sports activity enhance the risk of sudden death in adolescents and young adults?.J Am Coll Cardiol. 2003; 42: 1959-1963
- Department of Defense Cardiovascular Death Registry G. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance.J Am Coll Cardiol. 2011; 58: 5
- Sudden death in young adults: a 25-year review of autopsies in military recruits.Ann Intern Med. 2004; 141: 829-834
- Incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes: a decade in review.Circulation. 2015; 132: 10-19
- Incidence and etiology of sudden cardiac arrest and death in high school athletes in the United States.Mayo Clin Proc. 11th. 91. Elsevier, 2016: 1493-1502https://doi.org/10.1016/j.mayocp.2016.07.021
- Pathogeneses of sudden cardiac death in national collegiate athletic association athletes.Circ Arrhythmia Electrophysiol. 2014; 7: 198-204
- Incidence and etiology of sports-related sudden cardiac death in Denmark—implications for preparticipation screening.Heart Rhythm. 2010; 7: 1365-1371
- The magnitude of sudden cardiac death in the young: a death certificate-based review in England and Wales.Europace. 2009; 11: 1353-1358
- Sudden death in the young.Heart rhythm. 2005; 2: 1277-1282
- Sudden death in sports among young adults in Norway.Eur J Prev Cardiol. 2010; 17: 337-341
- Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.Circulation. 2007; 115: 1643-1655
- Arrhythmias in myocarditis: state of the art.Heart Rhythm. 2019; 16: 793-801
- Presentation, patterns of myocardial damage, and clinical course of viral myocarditis.Circulation. 2006; 114: 1581-1590
- Sex differences, genetic and environmental influences on dilated cardiomyopathy.J Clin Med. 2021; 10: 2289
- High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction.Circulation. 2005; 111: 887-893
- 2022 ACC expert Consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of cardiology solution set oversight committee.J Am Coll Cardiol. 2022; 79: 1717-1756https://doi.org/10.1016/j.jacc.2022.02.003
- Myocarditis and pericarditis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.Vaccine. 2022; 40: 1499-1511
- Clinical considerations: myocarditis and pericarditis after receipt of mRNA COVID-19 vaccines among adolescents and young adults.(Available at:) (Accessed May 23, 2022)
- Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations.J Am Coll Cardiol. 2018; 72: 3158-3176
- Risk of myocarditis from COVID-19 infection in people under age 20: a population-based analysis.medRxiv. 2021;
- Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry.JAMA Cardiol. 2021; 6: 1078-1087
- SARS-CoV-2 cardiac involvement in young competitive athletes.Circulation. 2021; 144: 256-266
- COVID-19 vaccine safety updates advisory committee on immunization practices (ACIP).(Available at:)https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-06/03-COVID-Shimabukuro-508.pdf(Accessed February 15, 2022)Date: 2021
- Idiopathic giant-cell myocarditis—natural history and treatment.N Engl J Med. 1997; 336: 1860-1866
- Cardiac sarcoidosis.J Am Coll Cardiol. 2016; 68: 411-421
- Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries.Eur Heart J. 2019; 40: 3121-3128
- Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members.Circ Cardiovasc Genet. 2015; 8: 437-446
- Do genes influence susceptibility to myocarditis?.American College of Cardiology Foundation, Washington DC2021: 593-594
- Arrhythmogenic right ventricular cardiomyopathy.N Engl J Med. 2017; 376: 61-72
- Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.Circulation. 2010; 121: 1533-1541
- Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity.J Am Coll Cardiol. 2008; 52: 2175-2187
- Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies.J Am Coll Cardiol. 2016; 68: 2440-2451
- Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy.Circulation. 2020; 141: 1872-1884
- Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria.Int J Cardiol. 2020; 319: 106-114
- Fabry's disease.Lancet. 2008; 372: 1427-1435
- Immune-Mediated myocarditis in Fabry disease cardiomyopathy.J Am Heart Assoc. 2018; 7: e009052
- Dilated cardiomyopathy.Nat Rev Dis primers. 2019; 5: 1-19
- Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n.Am J Physiology-Heart Circulatory Physiol. 2012; 302: H1726-H1736
- The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice.Biol Sex Differences. 2011; 2: 1-13
- Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.Nat Rev Cardiol. 2021; 18: 169-193
- Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition.J Virol. 2021; 95: e01368-21
- Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers.PLoS Pathog. 2014; 10: e1004045
- Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes.Cell Host & Microbe. 2009; 6: 367-380
- Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence.Proc Natl Acad Sci. 2014; 111: 6413-6418
- Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages.J Cell Biol. 2009; 186: 255-268
- Modification of cellular autophagy protein LC3 by poliovirus.J Virol. 2007; 81: 12543-12553
- Exercise training can induce cardiac autophagy at end-stage chronic conditions: insights from a graft-versus-host-disease mouse model.Brain Behav Immun. 2014; 39: 56-60
- Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials.Heart Fail Rev. 2019; 24: 535-547
- Exercise induced augmentation of cellular and humoral autoimmunity associated with increased cardiac dilatation in experimental autoimmune myocarditis.Cardiovasc Res. 1987; 21: 217-222
- Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence.Eur J Epidemiol. 1989; 5: 348-350
- Interferon and neutralizing antibody in sera of exercised mice with coxsackievirus B-3 myocarditis.Proc Soc Exp Biol Med. 1976; 151: 333-338
- Effects of exercise on coxsackie A9 myocarditis in adult mice.Proc Soc Exp Biol Med. 1964; 117: 777-782
- Physiological mitochondrial fragmentation is a normal cardiac adaptation to increased energy demand.Circ Res. 2018; 122: 282-295
- Sex differences in inflammation, redox biology, mitochondria and autoimmunity.Redox Biol. 2020; 31: 101482
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.Eur Heart J. 2013; 34: 2636-2648
- Prevalence and clinical implications of persistent or exertional cardiopulmonary symptoms following SARS-CoV-2 infection in 3597 collegiate athletes: a study from the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA).Br J Sports Med. 2021; 56: 913-918
- Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening.JAMA Cardiol. 2021; 6: 745-752
- Myocarditis.N Engl J Med. 2009; 360: 1526-1538
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.Circulation. 2013; 128: 1810-1852
- Evolving diagnostic criteria for arrhythmogenic cardiomyopathy.J Am Heart Assoc. 2021; 10: e021987
- Management of myocarditis-related cardiomyopathy in adults.Circ Res. 2019; 124: 1568-1583
- Cardiac magnetic resonance imaging in myocarditis reveals persistent disease activity despite normalization of cardiac enzymes and inflammatory parameters at 3-month follow-up.Circ Heart Fail. 2017; 10: e004262
- 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society.J Am Coll Cardiol. 2018; 72: e91-e220
- Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association.Circulation. 2020; 141: e69-e92
- Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology.J Am Coll Cardiol. 2015; 66: 2362-2371
- Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications.J Intern Med. 2013; 274: 331-341
- COVID-19–myocarditis and return to play: reflections and recommendations from a Canadian working group.Can J Cardiol. 2021; 37: 1165-1174
- A prospective pilot study to identify a myocarditis cohort who may safely resume sports activities 3 months after diagnosis.J Cardiovasc Translational Res. 2021; 14: 670-673
- Prognostic impact of late gadolinium enhancement by cardiovascular magnetic resonance in myocarditis: a systematic review and meta-analysis.Circ Cardiovasc Imaging. 2021; 14: e011492
Article info
Footnotes
The authors have nothing to disclose.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
